CXCL12 and neoplasm: Several lines of evidence currently oppose the possibility that the observed diverse migratory, invasive, and apoptotic responses of the various tumor cells to a combination of CXCL12 and CXCL11 would be due to the differential use of CXCR3A and CXCR3B.